Last reviewed · How we verify

Ethiodized Oil-based emulsion — Competitive Intelligence Brief

Ethiodized Oil-based emulsion (Ethiodized Oil-based emulsion) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Radiopaque contrast agent / Immunomodulatory emulsion. Area: Oncology.

phase 3 Radiopaque contrast agent / Immunomodulatory emulsion Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Ethiodized Oil-based emulsion (Ethiodized Oil-based emulsion) — Assistance Publique - Hôpitaux de Paris. Ethiodized oil-based emulsion acts as a radiopaque contrast agent and immunomodulatory agent that enhances imaging and may stimulate immune responses against cancer cells.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ethiodized Oil-based emulsion TARGET Ethiodized Oil-based emulsion Assistance Publique - Hôpitaux de Paris phase 3 Radiopaque contrast agent / Immunomodulatory emulsion

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Radiopaque contrast agent / Immunomodulatory emulsion class)

  1. Assistance Publique - Hôpitaux de Paris · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ethiodized Oil-based emulsion — Competitive Intelligence Brief. https://druglandscape.com/ci/ethiodized-oil-based-emulsion. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: